Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06055868 · ClinicalTrials.gov registry record
People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
A clinical trial of HIV Infections and Oropharyngeal Squamous Cell Carcinoma, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 144
- Enrollment target
- 1
- Study location
NCT06055868: Recruiting study of HIV Infections and Oropharyngeal Squamous Cell Carcinoma, sponsored by University of California, San Francisco.
NCT06055868 is a study of HIV Infections and Oropharyngeal Squamous Cell Carcinoma that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 144 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06055868, a study of HIV Infections and Oropharyngeal Squamous Cell Carcinoma, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 144 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an exploratory qualitative study among People Living With HIV (PLWH) of diverse racial/ethnic and sexual and gender minority (SGM) identities to explore individual, interpersonal, and structural oral health equity factors that serve as barriers or facilitators of accessing oral health care, knowledge and perceptions of human papillomavirus (HPV) vaccination and Oral squamous cell carcinoma (OSCC) /Oropharyngeal squamous cell carcinoma (OPSCC), and to collect recommendations on how to increase access to oral health care and engage PLWH in OSCC/OPSCC prevention.
Primary Outcome
Participants will complete a baseline questionnaire which will aid in the formation of the focus group with other individuals of shared identity. The Focus Group Discussions (FGDs) will be transcribed, coded, and the focus group guide will be updated following the Grounded Theory qualitative research methodology. The "data" from the FGD are the audio recordings and the transcripts. The digital transcript of each focus group will be uploaded to the software MAXQDA to aid with coding and analysis
Conditions Studied
Interventions
- OTHER Questionnaires
- OTHER Group Meeting (Focus Group)
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2025-02-13 |
| Est. Completion | 2029-11-30 |
What NCT06055868 shows while recruiting
NCT06055868 is an observational study that tracks outcomes without assigning an intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (68% lower).
The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Questionnaires is the first listed.
NCT06055868 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06055868 about?
NCT06055868 is a clinical study titled "People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity". This is an exploratory qualitative study among People Living With HIV (PLWH) of diverse racial/ethnic and sexual and gender minority (SGM) identities to explore individual, interpersonal, and structural oral health equity factors that serve as barriers or facilitators of accessing oral health care, ...
What is the current status of trial NCT06055868?
This trial is currently recruiting. The enrollment target is 144 participants. The study started on 2025-02-13. Estimated completion is 2029-11-30.
What conditions does trial NCT06055868 study?
This clinical trial studies the following conditions: HIV Infections, Oropharyngeal Squamous Cell Carcinoma, Oral Squamous Cell Carcinoma.
What interventions are being tested in trial NCT06055868?
The interventions under investigation include: Questionnaires (OTHER), Group Meeting (Focus Group) (OTHER).
Who is sponsoring clinical trial NCT06055868?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06055868 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06055868's enrollment target sits among peer trials
144 218th of 542 higher than 324 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI